Celcuity, Inc. 2.75% 01-AUG-2031Celcuity, Inc. 2.75% 01-AUG-2031Celcuity, Inc. 2.75% 01-AUG-2031

Celcuity, Inc. 2.75% 01-AUG-2031

No trades
See on Supercharts

Key terms


Outstanding amount
‪201.25 M‬USD
Face value
1,000.00USD
Minimum denomination
1,000.00USD
Coupon
2.75% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
Maturity date
Aug 1, 2031
Term to maturity
5 years

About Celcuity, Inc. 2.75% 01-AUG-2031


Sector
Health Technology
Industry
Medical Specialties
Home page
Issue date
Aug 1, 2025
ISIN
US15102KAA88
FIGI
BBG01WF3VC86
Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

See how Celcuity, Inc. is moving with its highest-yielding bonds.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.